Scenarios that move OLMA

Olema Pharmaceuticals, Inc. - Common Stock

Scenarios that move OLMA: 1 analysis, 1 positive, 0 negative.

1. 2026-09-14 · AstraZeneca's Etcamah fails late-stage study in first-line breast cancer — ▲ · impact +42 · confidence low · horizon immediate

All scenarios · Run a scenario · Pricing